Preliminary findings of a dedicated ocular myasthenia gravis rating scale: The OMGRate
Preliminary findings of a dedicated ocular myasthenia gravis rating scale: The OMGRate
There is a pressing need for a robust rating scale for ocular myasthenia gravis (OMG). Rating scales for myasthenia gravis (MG) research have a predominant focus on generalised disease. We present results of the first dedicated rating scale for OMG: the ocular myasthenia gravis rating scale (OMGRate). The OMGRate was developed through an international collaboration between neuromuscular and neuro-ophthalmology experts in OMG. It comprises two components: a physician- examination (OMGRate-e) and a patient questionnaire (OMGRate-q).. The OMGRate was prospectively validated in patients attending a neuro-ophthalmology clinic from April 2017 to October 2018. External validity and reliability of OMGRate were evaluated using validated MG rating scales: the Myasthenia Gravis Composite (MGC), the Myasthenia Gravis Quality of Life (MG-QOL), and the ocular component from the Myasthenia Gravis Impairment Index questionnaire (MGII). Two hundred and eleven assessments were completed in 104 patients (67 males, mean age 55 y, range 18–86 y). There was very good external validity of the OMGRate: good correlation between OMGRate-e and MGC (r = 0.64, 95% confidence intervals [CI] 0.54–0.74, p < .0001); excellent correlation between OMGRate-q and MGII (r = 0.85, 95% CI 0.78–0.91, p < .0001) and good correlation between OMGRate and MG-QOL (r = 0.68, 95% CI 0.60–0.77, p < .0001). A higher correlation of OMGRate and MG-QOL compared with MGC and MG-QOL (r = 0.47, 95% CI 0.34–0.59, p < .0001) suggests that OMGRate is better able to capture significant QOL information in patients with OMG. It had excellent reliability with an intraclass correlation coefficient of 0.83 (95% CI 0.67–0.92). Feedback from examiners and patients indicated that the OMGRate was easy to use. In conclusion, OMGRate is an easy-to-use, valid and reliable rating scale for monitoring the severity of OMG.
Wong, Sui
31a39145-d5ca-4edf-a874-dfc68681ffed
Eggenberger, Eric
e5ae33ed-afd7-4eec-861e-973edbe6e0ea
Cornblath, Wayne
ef98a756-9414-4885-946f-c4020e354cae
Xhepa, Alba
910503ac-96a0-4ce3-8508-e80a43e7353a
Miranda, Eduardo
35bee145-203d-41c3-a86c-65582afd08bb
Lee, Helena
5d36fd1e-9334-4db5-b201-034d147133fb
Burke, Ailbhe
2adc864b-67bf-450e-b373-779075ccd0b1
Barnett, Carolina
449e5347-9ca3-4171-9b83-95664e9d5f24
Wong, Sui
31a39145-d5ca-4edf-a874-dfc68681ffed
Eggenberger, Eric
e5ae33ed-afd7-4eec-861e-973edbe6e0ea
Cornblath, Wayne
ef98a756-9414-4885-946f-c4020e354cae
Xhepa, Alba
910503ac-96a0-4ce3-8508-e80a43e7353a
Miranda, Eduardo
35bee145-203d-41c3-a86c-65582afd08bb
Lee, Helena
5d36fd1e-9334-4db5-b201-034d147133fb
Burke, Ailbhe
2adc864b-67bf-450e-b373-779075ccd0b1
Barnett, Carolina
449e5347-9ca3-4171-9b83-95664e9d5f24
Wong, Sui, Eggenberger, Eric, Cornblath, Wayne, Xhepa, Alba, Miranda, Eduardo, Lee, Helena, Burke, Ailbhe and Barnett, Carolina
(2019)
Preliminary findings of a dedicated ocular myasthenia gravis rating scale: The OMGRate.
Journal of Neuro-Ophthalmology.
(doi:10.1080/01658107.2019.1660686).
Abstract
There is a pressing need for a robust rating scale for ocular myasthenia gravis (OMG). Rating scales for myasthenia gravis (MG) research have a predominant focus on generalised disease. We present results of the first dedicated rating scale for OMG: the ocular myasthenia gravis rating scale (OMGRate). The OMGRate was developed through an international collaboration between neuromuscular and neuro-ophthalmology experts in OMG. It comprises two components: a physician- examination (OMGRate-e) and a patient questionnaire (OMGRate-q).. The OMGRate was prospectively validated in patients attending a neuro-ophthalmology clinic from April 2017 to October 2018. External validity and reliability of OMGRate were evaluated using validated MG rating scales: the Myasthenia Gravis Composite (MGC), the Myasthenia Gravis Quality of Life (MG-QOL), and the ocular component from the Myasthenia Gravis Impairment Index questionnaire (MGII). Two hundred and eleven assessments were completed in 104 patients (67 males, mean age 55 y, range 18–86 y). There was very good external validity of the OMGRate: good correlation between OMGRate-e and MGC (r = 0.64, 95% confidence intervals [CI] 0.54–0.74, p < .0001); excellent correlation between OMGRate-q and MGII (r = 0.85, 95% CI 0.78–0.91, p < .0001) and good correlation between OMGRate and MG-QOL (r = 0.68, 95% CI 0.60–0.77, p < .0001). A higher correlation of OMGRate and MG-QOL compared with MGC and MG-QOL (r = 0.47, 95% CI 0.34–0.59, p < .0001) suggests that OMGRate is better able to capture significant QOL information in patients with OMG. It had excellent reliability with an intraclass correlation coefficient of 0.83 (95% CI 0.67–0.92). Feedback from examiners and patients indicated that the OMGRate was easy to use. In conclusion, OMGRate is an easy-to-use, valid and reliable rating scale for monitoring the severity of OMG.
Text
01658107.2019
- Version of Record
Restricted to Repository staff only
Request a copy
More information
Accepted/In Press date: 23 August 2019
e-pub ahead of print date: 9 October 2019
Identifiers
Local EPrints ID: 436840
URI: http://eprints.soton.ac.uk/id/eprint/436840
PURE UUID: 38982229-3d7a-490d-b004-6b2a5f638554
Catalogue record
Date deposited: 10 Jan 2020 17:34
Last modified: 17 Mar 2024 03:38
Export record
Altmetrics
Contributors
Author:
Sui Wong
Author:
Eric Eggenberger
Author:
Wayne Cornblath
Author:
Alba Xhepa
Author:
Eduardo Miranda
Author:
Ailbhe Burke
Author:
Carolina Barnett
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics